Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics.

Literature DB >> 22896807

The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics.

Craig W Lindsley.

Abstract

Mesh：

Substances：

Year: 2012 PMID： 22896807 PMCID： PMC3419448 DOI： 10.1021/cn3000923

Source DB: PubMed Journal: ACS Chem Neurosci ISSN： 1948-7193 Impact factor: 4.418

× No keyword cloud information.

2 in total

1. The top prescription drugs of 2009 in the US: CNS therapeutics rank among highest grossing.

Authors: Craig W Lindsley
Journal: ACS Chem Neurosci Date: 2010-06-16 Impact factor: 4.418

2. The top prescription drugs of 2010 in the United States: antipsychotics show strong growth.

Authors: Craig W Lindsley
Journal: ACS Chem Neurosci Date: 2011-06-15 Impact factor: 4.418

2 in total

22 in total

1. Antidepressant Use in the Elderly Is Associated With an Increased Risk of Dementia.

Authors: Chenkun Wang; Sujuan Gao; Hugh C Hendrie; Joe Kesterson; Noll L Campbell; Anantha Shekhar; Christopher M Callahan
Journal: Alzheimer Dis Assoc Disord Date: 2016 Apr-Jun Impact factor: 2.703

2. 2012 trends and statistics for prescription medications in the United States: CNS therapeutics continue to hold leading positions.

Authors: Craig W Lindsley
Journal: ACS Chem Neurosci Date: 2013-08-21 Impact factor: 4.418

3. The top prescription drugs of 2012 globally: biologics dominate, but small molecule CNS drugs hold on to top spots.

Authors: Craig W Lindsley
Journal: ACS Chem Neurosci Date: 2013-06-19 Impact factor: 4.418

4. Geographic region and racial variations in polypharmacy in the United States.

Authors: Winn Cashion; William McClellan; George Howard; Abhinav Goyal; David Kleinbaum; Michael Goodman; Valerie Prince; Paul Muntner; Leslie A McClure; Ann McClellan; Suzanne Judd
Journal: Ann Epidemiol Date: 2015-02-07 Impact factor: 3.797

5. Lack of relationship between plasma levels of escitalopram and QTc-interval length.

Authors: Mar Carceller-Sindreu; Javier de Diego-Adeliño; Maria J Portella; Xavier Garcia-Moll; Maria Figueras; Aina Fernandez-Vidal; Josep M Queraltó; Dolors Puigdemont; Enric Álvarez
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2017-01-23 Impact factor: 5.270

6. 2013 Statistics for global prescription medications: CNS therapeutics maintain a leading position among small molecule therapeutics.

Authors: Craig W Lindsley
Journal: ACS Chem Neurosci Date: 2014-04-16 Impact factor: 4.418

7. Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.

Authors: Yuan Ji; Daniel J Schaid; Zeruesenay Desta; Michiaki Kubo; Anthony J Batzler; Karen Snyder; Taisei Mushiroda; Naoyuki Kamatani; Evan Ogburn; Daniel Hall-Flavin; David Flockhart; Yusuke Nakamura; David A Mrazek; Richard M Weinshilboum
Journal: Br J Clin Pharmacol Date: 2014-08 Impact factor: 4.335